This study provides the first evidence that hepatic lipid droplet-coating kinase TAOK3 is a critical regulatory node controlling liver lipotoxicity and susceptibility to NAFLD. This evidence concerns the gene TAOK3 and metabolic dysfunction-associated steatotic liver disease.